The 37th Annual Congress of the European Association of Nuclear Medicine (EANM’24) was held in Hamburg, Germany on October 19-23, 2024.
As the world's most valuable nuclear medicine conference, the EANM annual congress has built up a great platform for global nuclear medicine technicians to exchange and discuss the latest theranostic advances, the most impactful clinical evidence, the most recently developed radiopharmaceuticals, and the most novel imaging and detection technologies, to ensure that all patients can benefit from timely diagnosis and effective treatment.
Several topics were discussed over this year’s Technologists’ Track, include whole-body multimodality imaging principles, PET-CT in oncologic diseases’ staging applications, radio-guided surgery, brain PET studies, as well as recent advancements regarding artificial intelligence and radiomics.
Julia Fricke, Department of Nuclear Medicine, University Hospital in Basel, Switzerland, won the EANM Marie Curie Award for her insightful research titled ‘Therapy with the somatostatin receptor antagonist DOTA-LM3 labeled with terbium-161: Interim results of the Phase 0 Study in patients with gastroenteropancreatic neuroendocrine tumors’.
Valentina Garibotto, EANM Congress Chair (2023–2025) expressed, “Indeed, in my vision, one central mission of the EANM’s annual congress is to motivate and inspire the youngest members of our community, who will be shaping the future of our field. The only everlasting element in our discipline is change, making adaption essential to guarantee our continued success. This can only be achieved with the contribution and active involvement of younger specialists and collaborators, who will bring our developments and advances forward.”
With the professional knowledge and technical experience accumulated in the field of nuclear medicine over past years, United Well gives full play to its unique advantages in drug research and development, gives strong energy to many innovative enterprises in this field, and brings new hope to the increasing number of cancer patients.
